| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Sabine Pereyre | Q42319674 |
| Cécile Bébéar | Q42319677 | ||
| P2093 | author name string | Julien Goret | |
| P2860 | cites work | The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America | Q22242904 |
| Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults | Q22242958 | ||
| Guidelines for the management of adult lower respiratory tract infections--full version | Q28249185 | ||
| Polymerase chain reaction is superior to serology for the diagnosis of acute Mycoplasma pneumoniae infection and reveals a high rate of persistent infection | Q33343116 | ||
| Hemolytic uremic syndrome complicating Mycoplasma pneumoniae infection | Q33408648 | ||
| Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children | Q34299489 | ||
| The spread of Mycoplasma pneumoniae is polyclonal in both an endemic setting in France and in an epidemic setting in Israel | Q34305578 | ||
| Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae | Q34352193 | ||
| Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan | Q34370748 | ||
| Multiple-locus variable-number tandem-repeat analysis of mycoplasma pneumoniae clinical specimens and proposal for amendment of MLVA nomenclature | Q34758860 | ||
| Investigations of Mycoplasma pneumoniae infections in the United States: trends in molecular typing and macrolide resistance from 2006 to 2013. | Q34916280 | ||
| In vitro and in vivo profiles of ACH-702, an isothiazoloquinolone, against bacterial pathogens | Q35005092 | ||
| A single-tube multiple-locus variable-number tandem-repeat analysis of Mycoplasma pneumoniae clinical specimens by use of multiplex PCR-capillary electrophoresis | Q35036176 | ||
| Gene and cytokine profile analysis of macrolide-resistant Mycoplasma pneumoniae infection in Fukuoka, Japan | Q35065349 | ||
| Macrolide-resistant Mycoplasma pneumoniae in adults in Zhejiang, China | Q35105923 | ||
| Mycoplasma pneumoniae and Chlamydia spp. infection in community-acquired pneumonia, Germany, 2011-2012 | Q35130309 | ||
| Sequence analysis of the p1 adhesin gene of Mycoplasma pneumoniae in clinical isolates collected in Beijing in 2008 to 2009. | Q35139861 | ||
| In vitro antibacterial activity of AZD0914 against human Mycoplasmas and Ureaplasmas. | Q35607663 | ||
| International Mycoplasma pneumoniae typing study: interpretation of M. pneumoniae multilocus variable-number tandem-repeat analysis | Q35849350 | ||
| Macrolide-Resistant Mycoplasma pneumoniae, United States | Q35896987 | ||
| Molecular Detection and Characterization of Mycoplasma pneumoniae Among Patients Hospitalized With Community-Acquired Pneumonia in the United States | Q35952824 | ||
| Macrolide resistance in Mycoplasma pneumoniae, Israel, 2010 | Q35980166 | ||
| Macrolide resistance determination and molecular typing of Mycoplasma pneumoniae in respiratory specimens collected between 1997 and 2008 in The Netherlands | Q36022838 | ||
| Multiclonal origin of macrolide-resistant Mycoplasma pneumoniae isolates as determined by multilocus variable-number tandem-repeat analysis | Q36171318 | ||
| Emergence of Macrolide-Resistant Mycoplasma pneumoniae in Hong Kong Is Linked to Increasing Macrolide Resistance in Multilocus Variable-Number Tandem-Repeat Analysis Type 4-5-7-2. | Q36174011 | ||
| Mechanisms of drug resistance in Mycoplasma pneumoniae. | Q36266323 | ||
| Multilocus variable-number tandem-repeat analysis of Mycoplasma pneumoniae clinical isolates from 1962 to the present: a retrospective study | Q36362965 | ||
| Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia | Q36422675 | ||
| Multiple-locus variable-number tandem-repeat analysis of 201 Mycoplasma pneumoniae isolates from Beijing, China, from 2008 to 2011 | Q36558951 | ||
| Surveillance of macrolide-resistant Mycoplasma pneumoniae in Beijing, China, from 2008 to 2012 | Q36667124 | ||
| Nationwide surveillance of macrolide-resistant Mycoplasma pneumoniae infection in pediatric patients | Q37036562 | ||
| Macrolide resistance of Mycoplasma pneumoniae, South Korea, 2000-2011 | Q37085103 | ||
| Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China | Q37190747 | ||
| Comparative in vitro susceptibilities of human mycoplasmas and ureaplasmas to a new investigational ketolide, CEM-101. | Q37190851 | ||
| Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections | Q37255258 | ||
| Macrolide-resistant Mycoplasma pneumoniae pneumonia in adolescents and adults: clinical findings, drug susceptibility, and therapeutic efficacy | Q37263838 | ||
| More complications occur in macrolide-resistant than in macrolide-sensitive Mycoplasma pneumoniae pneumonia | Q37544810 | ||
| Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia | Q37679736 | ||
| The increased incidence of Mycoplasma pneumoniae in France in 2011 was polyclonal, mainly involving M. pneumoniae type 1 strains. | Q37847351 | ||
| Development of multiple-locus variable-number tandem-repeat analysis for molecular typing of Mycoplasma pneumoniae | Q37855549 | ||
| First report of macrolide-resistant strains and description of a novel nucleotide sequence variation in the P1 adhesin gene in Mycoplasma pneumoniae clinical strains isolated in France over 12 years. | Q37859031 | ||
| Mycoplasma pneumoniae: susceptibility and resistance to antibiotics. | Q37869911 | ||
| In vitro activity of levofloxacin against contemporary clinical isolates of Legionella pneumophila, Mycoplasma pneumoniae and Chlamydia pneumoniae from North America and Europe | Q37871838 | ||
| British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. | Q37929444 | ||
| Molecular characterizations of PCR-positive Mycoplasma pneumoniae specimens collected from Australia and China | Q38856963 | ||
| Genomic repeats, genome plasticity and the dynamics of Mycoplasma evolution | Q39600720 | ||
| Epidemiology and clinical manifestations of children with macrolide-resistant Mycoplasma pneumoniae pneumonia in Taiwan | Q40267338 | ||
| High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China. | Q40356665 | ||
| In vitro selection and characterization of resistance to macrolides and related antibiotics in Mycoplasma pneumoniae. | Q40469366 | ||
| Comparison of Molecular Characteristics of Mycoplasma pneumoniae Specimens Collected from the United States and China | Q40508315 | ||
| Detection of macrolide resistant Mycoplasma pneumoniae in England, September 2014 to September 2015. | Q40868497 | ||
| Prevalence, genotyping and macrolide resistance of Mycoplasma pneumoniae among isolates of patients with respiratory tract infections, Central Slovenia, 2006 to 2014. | Q40923171 | ||
| In vitro development of resistance to six and four fluoroquinolones in Mycoplasma pneumoniae and Mycoplasma hominis, respectively | Q41092975 | ||
| Regional Differences in Prevalence of Macrolide Resistance among Pediatric Mycoplasma pneumoniae Infections in Hokkaido, Japan | Q41112196 | ||
| In vitro activities of the newer quinolones garenoxacin, gatifloxacin, and gemifloxacin against human mycoplasmas. | Q41269280 | ||
| Nested PCR-Linked Capillary Electrophoresis and Single-Strand Conformation Polymorphisms for Detection of Macrolide-Resistant Mycoplasma pneumoniae in Beijing, China | Q41428012 | ||
| Macrolide resistance and azithromycin failure in a Mycoplasma genitalium-infected cohort and response of azithromycin failures to alternative antibiotic regimens | Q41583528 | ||
| Survey of macrolide-resistant Mycoplasma pneumoniae in children with community-acquired pneumonia in Switzerland | Q41726828 | ||
| Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis | Q42111895 | ||
| Single-nucleotide polymorphism PCR for the detection of Mycoplasma pneumoniae and determination of macrolide resistance in respiratory samples. | Q42217354 | ||
| Clinical outcomes and macrolide resistance in Mycoplasma pneumoniae infection in Scotland, UK. | Q42248698 | ||
| Multilocus variable-number tandem-repeat analysis-confirmed emergence of a macrolide resistance-associated mutation in Mycoplasma pneumoniae during macrolide therapy for interstitial pneumonia in an immunocompromised child. | Q42692693 | ||
| Activity of Garenoxacin against Macrolide-Susceptible and -Resistant Mycoplasma pneumoniae | Q42747636 | ||
| Macrolide-resistant Mycoplasma pneumoniae in humans, Ontario, Canada, 2010-2011. | Q42931029 | ||
| Clinical relevance of Mycoplasma pneumoniae macrolide resistance in children | Q42955500 | ||
| Characterization of macrolide resistance in Mycoplasma pneumoniae isolated from children in Shanghai, China | Q42967138 | ||
| Low rate of macrolide resistance in Mycoplasma pneumoniae strains in Germany between 2009 and 2012. | Q43110648 | ||
| Confirmed Mycoplasma pneumoniae endocarditis | Q43218792 | ||
| Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance | Q43722862 | ||
| Epidemic of Mycoplasma pneumoniae infection in Denmark, 2010 and 2011. | Q43744366 | ||
| Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis. | Q44242565 | ||
| Macrolide resistance determination and molecular typing of Mycoplasma pneumoniae by pyrosequencing. | Q44261827 | ||
| Reduced susceptibility to tetracyclines is associated in vitro with the presence of 16S rRNA mutations in Mycoplasma hominis and Mycoplasma pneumoniae | Q44475163 | ||
| Editorial commentary: infections due to macrolide-resistant Mycoplasma pneumoniae: now what? | Q44661608 | ||
| Increased detection of Mycoplasma pneumoniae infection in children in England and Wales, October 2011 to January 2012. | Q54323734 | ||
| Increased incidence of Mycoplasma pneumoniae infection in England and Wales in 2010: multiocus variable number tandem repeat analysis typing and macrolide susceptibility. | Q54372200 | ||
| Resistance of Mycoplasma pneumoniae to macrolides, lincomycin and streptogramin B. | Q54423516 | ||
| Resistance of Mycoplasma pneumoniae to erythromycin and other antibiotics | Q54681120 | ||
| Emergence of macrolide-resistant strains during an outbreak of Mycoplasma pneumoniae infections in children | Q59396607 | ||
| Levofloxacin for the treatment of Mycoplasma pneumoniae-associated meningoencephalitis in childhood | Q59396657 | ||
| Macrolide-resistant Mycoplasma pneumoniae in paediatric pneumonia | Q59396661 | ||
| A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients | Q82252204 | ||
| Rising rates of macrolide-resistant Mycoplasma pneumoniae in the central United States | Q83158581 | ||
| Antimicrobial activity of the novel pleuromutilin antibiotic BC-3781 against organisms responsible for community-acquired respiratory tract infections (CARTIs) | Q83353954 | ||
| Stevens-Johnson syndrome in a boy with macrolide-resistant Mycoplasma pneumoniae pneumonia | Q84017527 | ||
| Neuroinvasive Mycoplasma pneumoniae infection without intrathecal antibody response | Q84516459 | ||
| Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany | Q84572754 | ||
| [Clinical efficacy of tosufloxacin in children with pneumonia due to Mycoplasma pneumoniae] | Q85506706 | ||
| In vitro activities of 11 antimicrobial agents against macrolide-resistant Mycoplasma pneumoniae isolates from pediatric patients: results from a multicenter surveillance study | Q85538425 | ||
| Molecular characterization of macrolide resistance of a Mycoplasma pneumoniae strain that developed during therapy of a patient with pneumonia | Q86110757 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Mycoplasma pneumoniae | Q310904 |
| P304 | page(s) | 974 | |
| P577 | publication date | 2016-01-01 | |
| P1433 | published in | Frontiers in Microbiology | Q27723481 |
| P1476 | title | Mycoplasma pneumoniae: Current Knowledge on Macrolide Resistance and Treatment | |
| P478 | volume | 7 |
| Q60947776 | A Case of Influenza B and Coinfection in an Adult |
| Q47645795 | A Case of Macrolide-Refractory Mycoplasma pneumoniae Pneumonia in Pregnancy Treated with Garenoxacin. |
| Q40263755 | A Possible Novel Prosthetic Joint Infection Pathogen, Mycoplasma salivarium, Identified by Metagenomic Shotgun Sequencing. |
| Q90312686 | A Prospective, Open-label, Randomized Trial of Doxycycline Versus Azithromycin for the Treatment of Uncomplicated Murine Typhus |
| Q91834823 | Allele-specific real-time PCR testing for minor macrolide-resistant Mycoplasma Pneumoniae |
| Q89684181 | Annual and seasonal patterns in etiologies of pediatric community-acquired pneumonia due to respiratory viruses and Mycoplasma pneumoniae requiring hospitalization in South Korea |
| Q92782867 | Anti-Mycoplasma Activity of Daptomycin and Its Use for Mycoplasma Elimination in Cell Cultures of Rickettsiae |
| Q92967971 | Antimicrobial susceptibility and molecular characteristics of Mycoplasma pneumoniae isolates across different regions of China |
| Q50047524 | Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children |
| Q40064046 | Atypical bacterial pneumonia in the HIV-infected population |
| Q93183133 | Benefits and risks of therapeutic alternatives for macrolide resistant Mycoplasma pneumoniae pneumonia in children |
| Q52655633 | Clinical characteristics from co-infection with avian influenza A H7N9 and Mycoplasma pneumoniae: a case report. |
| Q93343610 | Clinical features and seasonal variations in the prevalence of macrolide-resistant Mycoplasma pneumoniae |
| Q58715860 | Comparison of the molecular characteristics of Mycoplasma pneumoniae from children across different regions of China |
| Q33801193 | Encouraging rational antibiotic use in childhood pneumonia: a focus on Vietnam and the Western Pacific Region. |
| Q61809827 | Genetic characterization of Mycoplasma pneumoniae isolated in Osaka between 2011 and 2017: Decreased detection rate of macrolide-resistance and increase of p1 gene type 2 lineage strains |
| Q90390830 | Immunochromatography for the diagnosis of Mycoplasma pneumoniae infection: A systematic review and meta-analysis |
| Q92282355 | Long-Term Low Rate of Macrolide-Resistant Mycoplasma pneumoniae Strains in Germany |
| Q58735304 | Look and Outlook on Enzyme-Mediated Macrolide Resistance |
| Q47137086 | Macrolide-resistant Mycoplasma pneumoniae prevalence and clinical aspects in adult patients with community-acquired pneumonia in China: a prospective multicenter surveillance study |
| Q39424555 | Mechanism of resistance acquisition and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children |
| Q92657488 | Molecular Typing of Mycoplasma pneumoniae Strains in Sweden from 1996 to 2017 and the Emergence of a New P1 Cytadhesin Gene, Variant 2e |
| Q93164177 | Multiple differences in pathogen-host cell interactions following a bacterial host shift |
| Q59791737 | Pathogenesis and Treatment of Neurologic Diseases Associated With Infection |
| Q98771324 | Periodic Genotype Shifts in Clinically Prevalent Mycoplasma pneumoniae Strains in Japan |
| Q61449807 | Role of Probiotics in Pneumonia in Children: A Short-Term Pilot Project |
| Q40476130 | Role of Serum Mycoplasma pneumoniae IgA, IgM, and IgG in the Diagnosis of Mycoplasma pneumoniae-Related Pneumonia in School-Age Children and Adolescents. |
| Q38692156 | Solithromycin: A novel ketolide antibiotic. |
| Q40115848 | Spontaneous pneumomediastinum, emphysema, and pulmonary bullae associated with refractory Mycoplasma pneumoniae pneumonia in a child |
| Q54268209 | Systemic fluoroquinolone prescriptions for hospitalized children in Belgium, results of a multicenter retrospective drug utilization study. |
| Q64960386 | The Role of Lipoproteins in Mycoplasma-Mediated Immunomodulation. |
| Q94476061 | The diagnostic value of serological tests and real-time polymerase chain reaction in children with acute Mycoplasma pneumoniae infection |
| Q40092525 | Value of serum Mycoplasma pneumoniae immunoglobulin in the diagnosis of mycoplasma-related pneumonia in newborns |
| Q90318629 | Xiyanping Plus Azithromycin Chemotherapy in Pediatric Patients with Mycoplasma pneumoniae Pneumonia: A Systematic Review and Meta-Analysis of Efficacy and Safety |
Search more.